This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1ah3

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1ah3.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1ah3.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1ah3| PDB=1ah3 | SCENE= }}
{{STRUCTURE_1ah3| PDB=1ah3 | SCENE= }}
-
'''ALDOSE REDUCTASE COMPLEXED WITH TOLRESTAT INHIBITOR'''
+
===ALDOSE REDUCTASE COMPLEXED WITH TOLRESTAT INHIBITOR===
-
==Overview==
+
<!--
-
BACKGROUND: Aldose reductase (AR) is an NADPH-dependent enzyme implicated in long-term diabetic complications. Buried at the bottom of a deep hydrophobic cleft, the NADPH coenzyme is surrounded by the conserved hydrophilic residues of the AR active site. The existence of an anionic binding site near the NADP+ has been determined from the structures of the complexes of AR with citrate, cacodylate and glucose-6-phosphate. The inhibitor zopolrestat binds to this anionic site, and in the hydrophobic cleft, after a change of conformation which opens a 'specificity' pocket. RESULTS: The crystal structures of the porcine AR holoenzyme and its complexes with the inhibitors tolrestat and sorbinil have been solved; these structures are important as tolrestat and sorbinil are, pharmaceutically, the most well-studied AR inhibitors. The active site of the holoenzyme was analyzed, and binding of the inhibitors was found to involve two contact zones in the active site: first, a recognition region for hydrogen-bond acceptors near the coenzyme, with three centers, including the anionic site; and second, a hydrophobic contact zone in the active-site cleft, which in the case of tolrestat includes the specificity pocket. The conformational change leading to the opening of the specificity pocket upon tolrestat binding is different to the one seen upon zopolrestat binding; this pocket binds inhibitors that are more effective against AR than against aldehyde reductase. CONCLUSIONS: The active site of AR adapts itself to bind tightly to different inhibitors; this happens both upon binding to the inhibitor's hydrophilic heads, and at the hydrophobic and specificity pockets of AR, which can change their shape through different conformational changes of the same residues. This flexibility could explain the large variety of possible substrates of AR.
+
The line below this paragraph, {{ABSTRACT_PUBMED_9195881}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 9195881 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_9195881}}
==About this Structure==
==About this Structure==
Line 29: Line 33:
[[Category: Inhibition]]
[[Category: Inhibition]]
[[Category: Oxidoreductase]]
[[Category: Oxidoreductase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 10:15:39 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 16:50:14 2008''

Revision as of 13:50, 30 June 2008

Image:1ah3.png

Template:STRUCTURE 1ah3

ALDOSE REDUCTASE COMPLEXED WITH TOLRESTAT INHIBITOR

Template:ABSTRACT PUBMED 9195881

About this Structure

1AH3 is a Single protein structure of sequence from Sus scrofa. Full crystallographic information is available from OCA.

Reference

A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil., Urzhumtsev A, Tete-Favier F, Mitschler A, Barbanton J, Barth P, Urzhumtseva L, Biellmann JF, Podjarny A, Moras D, Structure. 1997 May 15;5(5):601-12. PMID:9195881

Page seeded by OCA on Mon Jun 30 16:50:14 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1ah3"
Personal tools